Interviewtimes 
U.S. health official Johnson & Johnson has lifted the company’s 11-day ban on COVID-19 vaccines in just one dose. Scientific advisers have found that the effect is far greater than the risk of blood clots. It was then decided to remove the barrier. The government identified 15 of the 80 million beneficiaries of the vaccine who were found to be blood clots. They were all women. Those under the age of 50. Three of them died and four were hospitalized.
But finally on Friday, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) decided that a single dose of Johnson & Johnson’s company would play a key role in fighting the corona epidemic. The vaccine should also be used to warn of the dangers of blood clots. So that younger women can be vaccinated or choose any other option.
“Our decision places the highest priority on health and safety,” said Dr Rachel Obaleski, director of the CDC. “Our vaccine protection system is working,” he said. We have seen rare cases of millions of cases of Johnson & Johnson. We are constantly monitoring that. The U.S. decision comes after an investigation by CDC advisers. Those who voted 10 in favor of starting vaccination. But experts also warned of the danger.
